National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Clinical Announcement on
Intraperitoneal Therapy for Ovarian Cancer
    Posted: 01/04/2006    Updated: 10/04/2006
Related Pages
Search for Clinical Trials 1
NCI's PDQ® Cancer Clinical Trials Registry.

Ovarian Cancer Home Page 2
NCI's gateway for information about ovarian cancer.
Published Trial Results

Intraperitoneal Chemotherapy of Ovarian Cancer: A Review, With a Focus on Practical Aspects of Treatment 3
Abstract of article, from the Feb. 20, 2006, issue of the Journal of Clinical Oncology (J Clin Oncol. 2006 Feb 6; [Epub ahead of print]).

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer 4
Free access to the full article from the Jan. 5, 2006 issue of the New England Journal of Medicine. There is also an accompanying editorial 5.

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group study 6
PDF of the full article from the Jan. 2006 issue of Gynecologic Oncology. There is also an accompanying editorial 7.

Intraperitoneal Cisplatin Versus No Further Treatment: 8-year results of EORTC 55875 8
Abstract of article, from the Nov.-Dec. 2003 issue of the International Journal of Gynecological Cancer (Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:196-203).

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma 9
Abstract of article, from the Feb. 15, 2001, issue of the Journal of Clinical Oncology (J Clin Oncol. 2001 Feb 15;19(4):1001-7).

Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer 10
Abstract of article, from the Jan. 2001 issue of the International Journal of Gynecology & Obstetrics (Int J Gynaecol Obstet. 2001 Jan;72(1):55-60).

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer 11
Abstract of article, from the Feb. 2000 issue of journal Gynecologic Oncology (Gynecol Oncol. 2000 Feb;76(2):157-62).

A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer 12
Abstract of article, from the 1999 issue of the journal Oncology (Oncology. 1999;56(4):291-6).

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer 13
Abstract of article, from the Dec. 26, 1996, issue of the New England Journal of Medicine (N Engl J Med. 1996 Dec 26;335(26):1950-5).


Table of Links

1http://www.cancer.gov/clinicaltrials/search
2http://www.cancer.gov/cancertopics/types/ovarian
3http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d16461779%26query_hl%3d1%26itool%3dpubmed_docs
um
4http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fcontent.nejm.org%2fcgi%2fcontent%2ffull%2f354%2f1%2f34%3fijkey%3dS8ahBqS
fLAV3s%26keytype%3dref%26siteid%3dnejm
5http://content.nejm.org/cgi/content/full/354/1/77?ijkey=di38RLSwzczzw&keytype=r
ef&siteid=nejm
6http://www.cancer.gov/clinicaltrials/Gynecologic-Oncology
7http://www.cancer.gov/clinicaltrials/Gynecologic-Oncology-Editorial-PDF
8http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d14656280%26query_hl%3d1%26itool%3dpubmed_docs
um
9http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d11181662%26query_hl%3d7%26itool%3dpubmed_docs
um
10http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d11146078%26query_hl%3d5%26itool%3dpubmed_docs
um
11http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d10637064%26query_hl%3d9%26itool%3dpubmed_docs
um
12http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d10343192%26query_hl%3d11%26itool%3dpubmed_doc
sum
13http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ncbi.nlm.nih.gov%2fentrez%2fquery.fcgi%3fcmd%3dRetrieve%26db%3dpubme
d%26dopt%3dAbstract%26list_uids%3d8960474%26query_hl%3d13%26itool%3dpubmed_docs
um